72-Gene Classifier for Predicting Prognosis of Estrogen Receptor–Positive and Node-Negative Breast Cancer Patients Using Formalin-Fixed, Paraffin-Embedded Tumor Tissues

Formalin Fixed Paraffin ◽

Tumor Tissues ◽

Formalin Fixed Paraffin Embedded ◽

Formalin Fixed

325 PUBLICATION Prognostic relevance of HER2 expression and gene amplification in estrogen receptor-positive lymph-node negative breast cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80623-8 ◽

2005 ◽

Vol 3 (2) ◽

pp. 91

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Cancer Patients ◽

Positive Lymph Node ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Node Negative ◽

Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors

Oncology Letters ◽

10.3892/ol.2018.9633 ◽

2018 ◽

Cited By ~ 2

Author(s):

Nobuyuki Arima ◽

Reiki Nishimura ◽

Tomofumi Osako ◽

Yasuhiro Okumura ◽

Masahiro Nakano ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Progesterone Receptor Status ◽

Breast Cancer Patients ◽

Ki 67 ◽

Node Negative ◽

Suitable Treatment ◽

Index Value

Abstract P2-09-32: Ki-67 index value and progesterone receptor status predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor positive and HER2 negative tumors

10.1158/1538-7445.sabcs17-p2-09-32 ◽

2018 ◽

Author(s):

N Arima ◽

R Nishimura ◽

T Osako ◽

Y Nishiyama ◽

Y Okumura ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Progesterone Receptor Status ◽

Breast Cancer Patients ◽

Ki 67 ◽

Node Negative ◽

Suitable Treatment ◽

Index Value

The first report of multicenter validation study of 95-gene classifier, a multi-gene prognostic assay of estrogen receptor positive and node negative breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdx362.035 ◽

2017 ◽

Vol 28 ◽

pp. v56

Author(s):

T. Kinoshita ◽

K. Aogi ◽

M. Takahashi ◽

K-I. Ito ◽

T. Oba ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Validation Study ◽

Breast Cancer Patients ◽

Node Negative ◽

First Report ◽

Multicenter Validation

Abstract P1-07-28: Retrospective analysis of clinicopathologic features predictive of oncotype DX discordance in estrogen receptor positive, node negative breast cancer patients

10.1158/1538-7445.sabcs17-p1-07-28 ◽

2018 ◽

Author(s):

KP Cascetta ◽

BS Zimmerman ◽

L Eggert ◽

MC Molot ◽

M Ru ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Retrospective Analysis ◽

Cancer Patients ◽

Oncotype Dx ◽

Clinicopathologic Features ◽

Breast Cancer Patients ◽

Node Negative ◽

Development of recurrence risk score using 95‑gene classifier and its application to formalin‑fixed paraffin‑embedded tissues in ER‑positive, HER2‑negative and node‑negative breast cancer

Oncology Reports ◽

10.3892/or.2019.7358 ◽

2019 ◽

Author(s):

Yasuto Naoi ◽

Yuria Saito ◽

Kazuki Kishi ◽

Masafumi Shimoda ◽

Naofumi Kagara ◽

...

Keyword(s):

Breast Cancer ◽

Risk Score ◽

Recurrence Risk ◽

Node Negative ◽

Formalin Fixed Paraffin ◽

Formalin Fixed Paraffin Embedded ◽

Er Positive ◽

Formalin Fixed

Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature

BMC Cancer ◽

10.1186/1471-2407-8-339 ◽

2008 ◽

Vol 8 (1) ◽

Cited By ~ 37

Author(s):

Andrew Tutt ◽

Alice Wang ◽

Charles Rowland ◽

Cheryl Gillett ◽

Kit Lau ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Distant Metastasis ◽

Risk Estimation ◽

Breast Cancer Patients ◽

Rt Pcr ◽

Node Negative ◽

Positive Breast Cancer

Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

10.1158/1538-7445.sabcs14-p6-08-10 ◽

2015 ◽

Cited By ~ 1

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision Making ◽

Clinical Decision ◽

Node Negative ◽

The Impact

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

10.1158/1538-7445.sabcs15-p2-08-01 ◽

2016 ◽

Cited By ~ 1

Author(s):

JA Sparano ◽

RJ Gray ◽

DF Makower ◽

KI Pritchard ◽

KS Albain ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Prospective Trial ◽

Low Risk ◽

Node Negative ◽

Abstract P4-08-27: The 21-gene Recurrence® (RS) Score assay in estrogen receptor positive node negative breast cancer: Real-world chemotherapy usage and patient characteristics within the intermediate and high-risk RS category

10.1158/1538-7445.sabcs18-p4-08-27 ◽

2019 ◽

Author(s):

D Le ◽

S Chia ◽

C Simmons ◽

C Speers ◽

L Gondara ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Real World ◽

Patient Characteristics ◽

Positive Node ◽

Node Negative ◽